Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | 2 | 1 | — | — | 3 |
Infections | D007239 | EFO_0000544 | — | — | 1 | 1 | — | — | 2 |
Communicable diseases | D003141 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | — | 3 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Drug common name | Enmetazobactam |
INN | enmetazobactam |
Description | Exblifep (enmetazobactam) is an unknown pharmaceutical. Enmetazobactam was first approved as Exblifep on 2024-02-22. |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[n+]1ccn(C[C@@]2(C)[C@H](C(=O)[O-])N3C(=O)C[C@H]3S2(=O)=O)n1 |
PDB | — |
CAS-ID | 1001404-83-6 |
RxCUI | — |
ChEMBL ID | CHEMBL4458276 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 80VUN7L00C (ChemIDplus, GSRS) |